60 mg tirzepatide vial Safe Pro Labs® Tirzepatide 60mg/3mL (20mg/mL) | Pipeline

Mitchell JL, Lyons HS, Walker JK, et al

Pharmacies accredited by the Pharmacy Compounding Accreditation Board (PCAB) may offer additional assurance of quality

Quick Navigation Report Overview Key Takeaways Product Type Analysis Route of Administration Analysis Application Analysis Distribution Channel Analysis Key Market Segments Drivers Restraints Opportunities Impact of Macroeconomic / Geopolitical Factors Latest Trends Regional Analysis Key Players Analysis Recent Developments Report Scope Report Overview Global GLP-1 Receptor Agonist Market size is expected to be worth around US$ 268.4 billion by 2034 from US$ 53.5 billion in 2024, growing at a CAGR of 17.5% during the forecast period 2025 to 2034

The treatment promotes skin tightening after weight loss by stimulating collagen and elastin production, resulting in firmer, more youthful-looking skin